SMS Lifesciences India Ltd Stock Price Today (NSE: SMSLIFE)

SMS Lifesciences India Ltd

1258.80+0.00 (+0.00%)
Market Closed

Fundamental Score

...

SMS Lifesciences India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

SMS Lifesciences India Ltd share price today is 1258.80, up +0.00% on NSE/BSE as of 22 June 2026. SMS Lifesciences India Ltd (SMSLIFE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 421.48 (Cr). The 52-week high for SMSLIFE share price is 1539.00 and the 52-week low is 1067.00. At a P/E ratio of 22.54x, SMSLIFE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 10.76% and a debt-to-equity ratio of 0.34.

SMS Lifesciences India Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
1384.00
Low
1204.80
Volume
1.3K
Change
+3.16%

SMS Lifesciences India Ltd share price chart: 3.16% return over the past month. 52-week high ₹1539.00, 52-week low ₹1067.00.

SMS Lifesciences India Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
1268.001268.001256.001258.8078.00 (Cr)
1247.901340.001247.901268.00130.00 (Cr)
1295.001295.001288.501288.5028.00 (Cr)
1299.001299.001265.101291.6075.00 (Cr)
1299.901299.901250.001299.0050.00 (Cr)
1300.101300.101271.301293.5053.00 (Cr)
1324.001324.001305.001305.00456.00 (Cr)
1336.901340.001315.001324.00758.00 (Cr)
1384.001384.001310.101315.80507.00 (Cr)
1354.001375.001330.001352.901.11K (Cr)

SMS Lifesciences India Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
1291.101384.001247.901258.80-2.50%
1393.501440.501204.801324.00-4.99%
1182.001539.001141.201393.50+17.89%
1123.201211.101100.601181.80+5.22%
1169.001259.901100.001127.70-3.53%
1138.601305.401067.001131.30-0.64%
1197.301376.601080.001132.70-5.40%
1143.601229.901143.301215.80+6.31%

AI Research Briefing

Powered by Gemini · 2026-04-13

Microcap API player riding government tailwinds; execute or evaporate.

Research Confidence
6.0/10Moderate
GOVT CAPEX DARK HORSEConsolidation, 1M: 17.67%, 3M: 22.27%, 6M: 6.17%Fair, P/E of 22.54x vs. industry P/E of 31.77x

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major catalysts found after live search.

CORE STORY (THE REAL GAME)

Why Now
  • Industry tailwinds from government support and focus on domestic manufacturing
  • Relatively discounted valuation compared to industry peers
  • Positive short-term price momentum
Potential Catalysts
  • Significant order wins in API/intermediates
  • Positive regulatory developments (e.g., USFDA approvals)
  • Successful capacity expansion and backward integration
Key Risks
  • Microcap liquidity risk
  • Negative free cash flow
  • Dependence on government incentives
Institutional Activity

FII: 0.0% (Δ -0.03%), DII: 0.03% (Δ 0.03%) - Minimal institutional interest

Macro Context

Government focus on promoting domestic pharma manufacturing is a tailwind

Cash Flow Quality

No, Free Cash Flow 5Y: ₹-58.51 Cr

3–6 Month Outlook

If Haleos Labs can capitalize on the government's push for domestic API manufacturing and improve its cash flow, it could see significant upside. However, execution is key, and the microcap nature of the stock adds significant risk.

Primary Thesis Risk

Reliance on government incentives and poor cash flow make this a binary bet.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

10.76%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.78%

Returns generated on total capital deployed

Average

Oper. Profit Margin (5Y Avg)

10.74%

Average operating profit margin over 5 years

Dividend Yield

0.11%

Annual dividend as % of current share price

SMS Lifesciences India Ltd Valuation Check

Good

Price to Earnings (P/E)

22.54x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.77x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

71.41%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.03%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

30.62%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

3.71%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

5.74%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

14.63%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

14.63%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.34x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.44x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-58.51 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

SMS Lifesciences India Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SMSLIFE across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Attractive Valuation (P/E: 22.54 vs Industry: 31.77)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (30.62%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Balanced Promoter Holding (71.41%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Negative Free Cash Flow (₹-58.51 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.03%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

SMS Lifesciences India Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare SMS Lifesciences India Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
46.6/100
1259
₹421.48
22.5
Average
10.76%
Average
11.78%
Average
0.3
Excellent
14.63%
Good
5.74%
Good
0.11%
65.2/100
1844
₹433738.68
37.6
Average
16.86%
Good
20.21%
Excellent
0.1
Excellent
23.78%
Excellent
9.87%
Good
0.89%
67.9/100
6798
₹170445.88
68.6
Average
15.35%
Good
20.44%
Excellent
0.0
Excellent
10.41%
Good
11.65%
Good
0.47%
65.3/100
4538
₹126430.62
58.4
Average
26.52%
Excellent
27.05%
Excellent
0.3
Excellent
13.84%
Good
7.72%
Good
0.86%
Cipla Ltd...
CIPLA500087
59/100
1418
₹123059.76
22.6
Average
17.77%
Good
22.72%
Excellent
0.0
Excellent
28.68%
Excellent
9.97%
Good
0.85%
59.2/100
1319
₹105224.96
18.2
Average
17.96%
Good
22.69%
Excellent
0.2
Excellent
22.28%
Excellent
13.26%
Good
0.63%
Lupin Ltd...
LUPIN500257
66.7/100
2276
₹95148.15
22.0
Average
20.62%
Excellent
21.30%
Excellent
0.3
Excellent
54.88%
Excellent
8.11%
Good
0.58%
68.7/100
957
₹94253.78
18.7
Average
21.21%
Excellent
24.31%
Excellent
0.4
Excellent
25.92%
Excellent
10.27%
Good
1.17%
50.6/100
2420
₹92012.53
52.6
Average
14.68%
Average
15.98%
Good
0.6
Good
11.73%
Good
15.79%
Excellent
0.04%
28.8/100
1436
₹70798.69
20.7
Average
11.08%
Average
14.18%
Average
0.2
Excellent
3.87%
Average
6.55%
Good
0.33%
59.5/100
5452
₹67075.29
28.5
Average
19.39%
Good
20.38%
Excellent
0.2
Excellent
13.93%
Good
9.21%
Good
0.80%

SMS Lifesciences India Ltd PE Ratio History

Historical price-to-earnings ratio for SMSLIFE — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202566.51₹1324.0019.9x
FY 202430.08₹1176.0039.1x
FY 202337.92₹529.6014x
FY 202283.76₹625.507.5x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

SMS Lifesciences India Ltd Dividend History

Annual cash dividends paid by SMSLIFE — dividend yield 0.11%

Financial YearDividends Paid (₹ Cr)
FY 20250.45 Cr
FY 20240.45 Cr
FY 20230.45 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

SMS Lifesciences India Ltd Quarterly Performance

Latest quarterly metrics for SMSLIFE — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

3.71%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

30.62%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

5.74%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

14.63%

Compounded annual net profit growth over 5 years

SMS Lifesciences India Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for SMSLIFE — calculated from daily price history

46RSI 14
Neutral — RSI 46

Momentum is balanced — neither overbought nor oversold.

SMA 50
1315
▼ Price below SMA 50 — Short-term bearish
SMA 200
1235
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
2K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

SMS Lifesciences India Ltd Financial Statements

Annual income statement, balance sheet and cash flow for SMS Lifesciences India Ltd (SMSLIFE) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for SMS Lifesciences India Ltd

About SMSLIFE (SMS Lifesciences India Ltd)

SMS Lifesciences India Ltd is a dynamic pharmaceutical company deeply rooted in the manufacturing and supply of vital active pharmaceutical ingredients (APIs) and advanced intermed...iates. Dedicated to advancing healthcare solutions, SMSLIFE focuses on developing and producing a wide spectrum of therapeutic solutions. With a commitment to quality and innovation, the company caters to diverse medical needs, ensuring access to affordable and effective medications globally. SMSLIFE operates with state-of-the-art manufacturing facilities, adhering to stringent regulatory standards to consistently deliver pharmaceutical products that meet the highest quality benchmarks. Their dedication extends to research and development, continuously seeking new pathways to enhance existing treatments and pioneer novel APIs that improve patient outcomes. SMSLIFE's therapeutic scope encompasses a broad range of critical healthcare areas, addressing prevalent and emerging medical conditions. This includes APIs for managing cardiovascular ailments, neurological disorders, and oncological treatments, showcasing their versatility. The company also offers solutions for infectious diseases, gastrointestinal issues, and endocrine imbalances, reflecting its commitment to comprehensive healthcare. SMSLIFE emphasizes innovation, constantly exploring advanced drug delivery systems and novel formulations to enhance the efficacy and patient experience. Their commitment to patient well-being is reflected in the meticulous care taken in manufacturing processes, adhering to strict quality control measures at every stage. This unwavering dedication underscores their mission to positively impact lives and contribute to a healthier world. Building on a foundation of trust and reliability, SMS Lifesciences India Ltd prides itself on its commitment to ethical business practices and sustainability. SMSLIFE cultivates strong partnerships with pharmaceutical companies, healthcare providers, and research institutions worldwide, fostering collaborative efforts that drive medical advancements. Their customer-centric approach ensures they are responsive to market needs and evolving healthcare trends. With a dedicated team of experienced scientists, engineers, and industry professionals, SMSLIFE continues to expand its capabilities and product portfolio. Driven by a passion for improving global health, SMSLIFE remains steadfast in its pursuit of excellence, striving to be a leading provider of high-quality APIs and intermediates that empower healthcare systems and enhance patient well-being.

Company Details

Symbol:SMSLIFE
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Talluri Veera Venkata Satyanarayana Murthy
MD & Executive Director
Mr. Nadella Rajendra Prasad
CFO & GM of Accounts & Finance
Mr. Trupti Ranjan Mohanty
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date

SMSLIFE Share Price: Frequently Asked Questions

What is the current share price of SMS Lifesciences India Ltd?

SMS Lifesciences India Ltd (SMSLIFE) trades at ₹1258.80 on NSE and BSE. Market cap ₹421.48 (Cr). Educational data only.

What is the P/E ratio of SMS Lifesciences India Ltd?

SMS Lifesciences India Ltd has a P/E of 22.54x vs industry average 31.77x.

What is the Bull Run score for SMS Lifesciences India Ltd?

SMS Lifesciences India Ltd has a Bull Run score of 46.6/100 based on 25+ financial parameters.

Does SMS Lifesciences India Ltd pay dividends?

SMS Lifesciences India Ltd has a dividend yield of 0.11%. Past dividends don't guarantee future payments.

What is the ROE of SMS Lifesciences India Ltd?

SMS Lifesciences India Ltd has ROE of 10.76%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of SMS Lifesciences India Ltd?

SMS Lifesciences India Ltd has debt-to-equity of 0.34.

Is SMS Lifesciences India Ltd a good investment?

Bull Run gives SMS Lifesciences India Ltd a score of 46.6/100. This is not investment advice — consult a SEBI-registered advisor.